Changes in invasive pneumococcal disease incidence in the era of the conjugate vaccine
Changes in invasive pneumococcal disease incidence in the era of the conjugate vaccine
Changes in invasive pneumococcal disease (IPD) incidence by serotype group among children aged <5 years (A) and adults aged ≥65 years (B), 1998 to 2007.
* 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in the United States for routine use among young children and infants in the second half of 2000.